Moriwaki et al. demonstrate that RIPK3 promotes cytokine production in CD11c + mononuclear phagocytes in an RHIMdependent, but kinase-independent manner. This necroptosis-independent function of RIPK3 is crucial for tissue repair in response to intestinal injury.
INTRODUCTION
Necroptosis is a type of regulated necrosis induced by several cell surface immune receptors such as tumor necrosis factor (TNF) receptor (TNFR), Toll-like receptor (TLR) 3 (TLR3), TLR4, interferon receptor, and T cell receptor . Receptor interacting protein kinase 3 (RIPK3) is a cytosolic master regulator of necroptosis (Moriwaki and Chan, 2013) . RIPK3 has an active serine-threonine kinase domain at the N terminus and a unique protein-protein interaction domain called the RIP homotypic interaction motif (RHIM) at the C terminus. Both kinase activity and RHIM are indispensable for necroptosis (Cho et al., 2009 ). RIPK3 interacts with other RHIM-containing proteins such as RIPK1 (Cho et al., 2009; He et al., 2009) , Toll/interleukin-1 (IL-1) receptor domain-containing adaptor protein inducing interferon b (TRIF) (He et al., 2011) , or DNA-dependent activator of interferon regulatory factor (DAI) (Upton et al., 2012) . RHIM-RHIM interaction leads to amyloid-like conformational change and enhancement of RIPK3 kinase activity (Li et al., 2012) . Activated RIPK3 phosphorylates the downstream adaptor MLKL (Sun et al., 2012) , which triggers oligomerization and translocation of MLKL to the plasma membrane (Cai et al., 2014; Chen et al., 2014; Dondelinger et al., 2014; Wang et al., 2014) .
Besides necroptosis, recent emerging evidence shows that RIPK3 also has necroptosis-independent functions . For example, RIPK3 stimulates nuclear factor kB (NF-kB)-dependent Il23p19 (Il23a) expression and pro-IL-1b processing downstream of TLR4 in bone marrow (BM)-derived dendritic cells (DCs) (BMDCs) . Similar RIPK3-dependent processing of pro-IL-1b has also been observed in BM-derived macrophages (BMDMs) treated with Smac mimetics and/or caspase inhibitors (Kang et al., 2013 (Kang et al., , 2015 Lawlor et al., 2015; Vince et al., 2012) . However, the relative contribution of necroptosis-dependent and -independent effects of RIPK3 in physiological inflammation has not been clearly elucidated.
Germline Ripk3-deficient mice have been used extensively to investigate the pathophysiological roles of RIPK3 . The resolution of inflammation in Ripk3 À/À mice has often been attributed as a consequence of blocking necroptosis. Strikingly, RIPK3 has recently been shown to have paradoxical function in promoting injury-induced tissue repair (Godwin et al., 2015) . In a mouse model of chemical-induced intestinal injury, RIPK3 facilitates expression of IL-23 and IL-1b, which in turn stimulates expression of the tissue repair cytokine IL-22. Thus, Ripk3 À/À mice developed sustained injury and inflammation . Based on these results, we asked whether RIPK3 promotes cytokine-induced tissue repair mainly through DCs. To achieve our goal, we generated ''knock-in'' mice expressing an RIPK3-GFP fusion reporter, as well as mice with tissue-specific deletion of the essential RHIM (Ripk3 DR/DR ). Using the RIPK3-GFP reporter mice, we found that RIPK3 was highly expressed in intestinal CD11c + CD11b + CD14 + CD103 À mononuclear phagocytes (MNPs). Deletion of RIPK3 RHIM in CD11c + cells fully recapitulated the severe intestinal inflammation observed in germline Ripk3 À/À mice. In contrast, kinase inactive RIPK3 knock-in mice did not exhibit hypersensitivity in response to chemical-induced colitis. Collectively, these results reveal cell-type-specific functions of RIPK3 in inflammation as well as the importance of RHIM-RHIM-mediated interaction in biological responses beyond necroptosis.
RESULTS
Generation of RIPK3-GFP Reporter Mice RIPK3 expression is often induced in tissues and cells during inflammation (Gautheron et al., 2014; Vitner et al., 2014) . To determine the physiological expression pattern of RIPK3 in quiescent and inflamed states, we generated RIPK3-GFP reporter mice in which the Ripk3 gene was fused in-frame with the eGfp sequence at the end of the RIPK3 translated sequence (Figure S1A) . Proper targeting of the Ripk3 locus was confirmed by Southern blot analysis (Figures S1A-S1C). We confirmed that RIPK3-GFP and wild-type RIPK3 were expressed at similar levels in Ripk3-gfp fl/+ mouse embryonic fibroblasts (MEFs) ( Figure 1A) . The percentage and number of T and B cells in the thymus and lymph node were normal in Ripk3 +/+ and Ripk3-gfp fl/fl mice (Figures S1D and S1E and data not shown). In addition, the composition of BM cells was unchanged in Ripk3-gfp fl/fl mice ( Figure S1F ). Hence, the RIPK3-GFP fusion protein faithfully reports in vivo expression of RIPK3 without disrupting RIPK3 function. (B and C) RIPK3 expression level in various subsets of immune cells in (B) spleen and (C) colonic lamina propria of Ripk3-gfp fl/fl reporter mice was determined by measuring the GFP fluorescence intensity using a flow cytometer (n = 2). CD19 + and CD3 + cells were defined as B and T cells, respectively. CD3 À CD19 À CD11c + cells were defined as DCs, except for colonic CD3 À CD19 À CD11c + CD11b + cells, which were defined as MNPs. CD3 À CD19 À CD11c À CD11b + cells were defined as macrophages (Mf), except for the CD3 À CD19 À CD11c À CD11b hi F4/80 lo cells, which were defined as monocytes (Mo Real-time PCR analysis using various mouse tissues showed the highest expression of the Ripk3 transcript in the spleen (Figure S2A) , suggesting that RIPK3 is highly expressed in immune cells. Indeed, strong GFP fluorescence signal was detected in various immune cells in the spleen ( Figure 1B ; Figure S2B ). In particular, splenic CD11c À CD11b high F4/80 low monocytes expressed RIPK3 at the highest level (Swirski et al., 2009) (Figure 1B) . In contrast, CD11c + CD11b + CD103 À MNPs, but not CD11c À CD11b + macrophages, showed the highest RIPK3 expression in the colon ( Figure 1C ; Figure S2C ). These results indicate that RIPK3 expression pattern in immune cells is highly variable in different cell types and tissues.
We next examined how inflammation might affect RIPK3 expression. To this end, we first injected lipopolysacharride (LPS) intraperitoneally and analyzed splenocytes for RIPK3 expression. Whereas RIPK3 expression in CD11c À CD11b high F4/ 80 low monocytes was further enhanced ( Figure 1D ), no significant change in GFP fluorescence was observed in other cell types (Figure S2D) . Moreover, RIPK3 protein expression in multiple tissues was unchanged despite clear induction of mature IL-1b (Figure S2E) . We previously showed that RIPK3 expression was increased in immune cells in the lamina propria of dextran sodium sulfate (DSS)-treated mice . Consistent with our previous results, RIPK3-GFP expression in colonic CD3 + T cells, but not other immune cells, was significantly increased upon DSS treatment ( Figure 1E ). In addition, higher RIPK3 expression was found in splenic CD44 hi effector-memory T cells compared with CD44 lo naive T cells ( Figure 1F ). In vitro activation of T cells by anti-CD3 and anti-CD28 antibodies or concanavalin A (Con A) also enhanced RIPK3 expression ( Figures 1G and S2F ). These results indicate that RIPK3 expression is highly inducible in T cells.
The RIPK3 RHIM Is Critical for RIPK3-Mediated Cell Death RIPK3 has two distinct functional domains: the kinase domain and the RHIM. Studies in knock-in mice expressing kinase inactive RIPK3 (Ripk3 K51A/K51A and Ripk3 D161N/D161N ) showed that RIPK3 kinase activity is crucial for necroptosis (Mandal et al., 2014; Newton et al., 2014) . In contrast, the physiological function of the RHIM has not been fully explored. To examine the physiological importance of the RHIM, we generated mice specifically lacking RIPK3 RHIM at the C terminus using Cre-loxP-mediated recombination ( Figure S3A ). We crossed the Ripk3-gfp fl/fl reporter mice with Sox2-Cre deletor mice to generate mice with germline deletion of the RHIM (Ripk3 DR/DR ) ( Figure S3B ). Loss of GFP fluorescence signal from all immune cell subsets from Ripk3 DR/DR mice was confirmed by flow cytometry (Figure 2A ). Because the stop codon of the Ripk3 gene was removed in the Ripk3 DR allele, we performed 3 0 -rapid amplification of cDNA ends (RACE) experiment using total RNA from Ripk3 DR/DR MEFs to determine the C-terminal amino acid sequence of the RIPK3-DRHIM protein.
The result revealed two possible mRNA transcripts generated from the Ripk3 DR allele ( Figure S3C ). DNA sequencing confirmed that both transcripts are expected to encode truncated and shorter RIPK3 that lack the RHIM ( Figure S3D ). A widely used rabbit polyclonal antibody that recognizes the C-terminal end of mouse RIPK3 revealed loss of full-length RIPK3 expression from Figure S3E , middle, RIPK3-P). In contrast, the anti-RIPK3 antibody clone 1G6.1.4 (RIPK3-G) recognized both wild-type RIPK3 and the RIPK3-DRHIM proteins that were absent in Ripk3 À/À cells (Figures 2B and 2C; Figure S3E , top, RIPK3-G) (Newton et al., 2014) . It should be noted that the RIPK3-G antibody detected two bands, both of which were specific for RIPK3 (Newton et al., 2014) , and that a single band of RIPK3-DRHIM protein was detected between these two wild-type (WT) bands ( Figures 2B and 2C ). This suggests that WT RIPK3 has two isoforms with different C-terminal sequences. Similar to mice expressing kinase inactive RIPK3 (Mandal et al., 2014) , RIPK3-DRHIM was expressed at a lower level compared with wild-type RIPK3 (Figures 2B and 2C, top) . This suggests that the RHIM and kinase activity are both required to stabilize RIPK3 protein expression.
To evaluate the impact of the RHIM on necroptosis, we treated Ripk3 DR/DR MEFs with TNF, the pan-caspase inhibitor zVAD-fmk (zVAD), and cycloheximide (CHX). In contrast with wild-type MEFs, Ripk3 DR/DR MEFs were resistant to TNF-induced necroptosis ( Figure 2D ). Ripk3 DR/DR BMDCs were also resistant to necroptosis induced by LPS and zVAD-fmk ( Figure 2E ) and zVAD-fmk and the Smac mimetic BV6 ( Figure 2F ), which induces autocrine TNF production (McComb et al., 2012) . In addition, Ripk3 DR/DR BMDMs were resistant to necroptosis induced by TNF, LPS, or polyinosinic-polycytidylic acid (polyIC) in the presence of the pan-caspase inhibitor zVAD-fmk ( Figure 2G ). Similar resistance to necroptosis was observed in Ripk3 À/À 3T3 cells reconstituted with HA-tagged RIPK3-DRHIM proteins ( Figure S3F ). By contrast, Ripk3 DR/DR BMDMs were equally sensitive to apoptosis induced by TNF, LPS, or poly(I:C) ( Figure S3G ). Moreover, Ripk3 DR/DR MEFs were resistant to apoptosis induced by the RIPK3 kinase inhibitor GSK'843 ( Figure S3H ), which causes caspase-8 activation through RHIM-mediated formation of the ripoptosome (Mandal et al., 2014; . Furthermore, Ripk3 DR/DR BMDCs were resistant to LPS-and CHX-induced caspase-3/8 activation and apoptosis (Figures S3I and S3J) . These results indicate that the RIPK3 RHIM is crucial for RIPK3-mediated necroptosis and apoptosis.
Caspase-8 À/À and Fadd À/À mice suffer from embryonic lethality caused by excessive necroptosis. This defect was completely rescued by inactivation of RIPK3 (Kaiser et al., 2011; Oberst et al., 2011) . We set up intercrosses of Fadd +/À Ripk3 DR/DR mice and found that Fadd À/À Ripk3 DR/DR mice were born at a Mendelian ratio ( Figure 2H ). Moreover, Fadd À/À Ripk3 DR/DR mice developed splenomegaly and lymphadenopathy ( Figure 2I ), and exhibited an expansion of CD3 + B220 + CD4 À CD8 À T cells in the spleen ( Figure 2J ). These phenotypes are characteristic of lpr and gld mice and the human autoimmune lymphoproliferative syndrome (ALPS) (Lenardo et al., 1999) . Hence, the RIPK3 RHIM is essential for necroptosis induced by various physiological stimuli, and deletion of the RHIM is functionally equivalent to the Ripk3 null allele.
The RHIM Is Essential for RIPK3-Dependent Cytokine Production
We previously reported that RIPK3 promotes NF-kB and inflammasome activation in BMDCs, and that these necroptosis-independent signaling functions are crucial for cytokine production downstream of TLR4 . In contrast with BMDCs treated with an RIPK3 kinase inhibitor , LPS-induced Il23p19 expression was reduced in Ripk3 DR/DR BMDCs ( Figure 3A ). TNF expression was also significantly diminished in LPS-treated Ripk3 DR/DR BMDCs ( Figure 3B ).
The RelB-p50 heterodimer potently induces Il23p19 expression by BMDCs in response to TLR stimulation (Shih et al., 2012) . This led us to test whether the RIPK3 RHIM is required for optimal RelB-p50 activation and cytokine expression . Indeed, LPS-induced nuclear translocation of RelB and p50 was similarly impaired in Ripk3 DR/DR and Ripk3 À/À BMDCs ( Figure 3C) .
In monocytes and DCs, LPS alone is sufficient to stimulate mature IL-1b secretion without a second inflammasome activation signal (He et al., 2013; Moriwaki et al., 2015) . This response requires an intact RIPK3, but not its kinase activity . LPS-induced IL-1b secretion was blunted in Ripk3 DR/DR BMDCs ( Figure 3D ), indicating that unlike the kinase activity, the RHIM is essential for this function. Mature IL-1b secretion is achieved by cleavage of pro-IL-1b by caspase-1 or caspase-8 (Latz et al., 2013) . The activation of both caspases was equally impaired in Ripk3 DR/DR and Ripk3 À/À BMDCs (Figures 3E and 3F) . RIPK3 stimulates caspase-8-mediated cleavage of pro-IL-1b through a ripoptosome-like complex (Kang et al., 2015; Lawlor et al., 2015; Moriwaki et al., 2015) . Assembly of this complex is enhanced by addition of GSK'843, which causes a conformational change of RIPK3 to promote interaction with RIPK1, FADD, and caspase-8 .
GSK'843 enhanced LPS-induced caspase-8 activation and IL-1b secretion in Ripk3 +/+ BMDCs (Figures 3G and 3H ). In contrast, GSK'843 failed to stimulate IL-1b secretion or caspase-8 activation in Ripk3 DR/DR BMDCs (Figures 3G and 3H ). Hence, unlike its kinase activity, the RIPK3 RHIM is essential for optimal LPSinduced NF-kB and inflammasome activation.
The RHIM of RIPK3 Mediates Protection against DSS-Induced Colitis DSS induces intestinal epithelial cell injury, and the resultant inflammation exhibits certain features resembling acute colitis. We previously showed that RIPK3-mediated expression of the cytokines IL-23, IL-1b, and IL-22 has a crucial role in the resolution of intestinal injury . To determine whether this tissue repair function of RIPK3 requires an intact RHIM, we treated Ripk3 DR/DR mice with DSS for 7 days, followed by recovery in normal drinking water for another 7 days. When compared with Ripk3 +/+ littermates, Ripk3 DR/DR mice suffered Ripk3
LPS (μg/ml) 0 100 0 100 0 100 Ripk3 from more severe body weight loss ( Figure 4A ). In addition, colon length after DSS treatment was significantly reduced in Ripk3 DR/DR mice ( Figure 4B ). In contrast, Ripk3 kd/kd (K51A) kinase inactive mice developed similar intestinal inflammation compared with co-housed Ripk3 +/À controls, in which RIPK3 protein is expressed at the level similar to RIPK3 K51A protein, as determined by body weight loss and colon length on day 15 (Figures 4C and 4D ). Because the kinase activity of RIPK3 is essential for necroptosis, these results indicate that RIPK3 mediates reparative inflammation in the intestine through RHIM-dependent, but necroptosis-and kinase-independent, mechanisms.
RIPK3 Promotes Injury-Induced Cytokine Expression by CD11c + Cells
Radiation BM chimera experiments revealed that RIPK3 expression in hematopoietic cells was important for protection against DSS-induced colitis . Adoptive transfer of LPS-treated Ripk3 +/+ BMDCs, but not Ripk3 À/À BMDCs, rescued production of the tissue-repair-associated cytokines IL-22, IL-23, and IL-1b. Because RIPK3 promotes optimal cytokine expression in BMDCs, we reasoned that DC-like cells are responsible for the protective effect of RIPK3 in DSS-induced colitis and tissue repair. To test our hypothesis, we generated DC-specific Ripk3 DR/DR (CD11c:Ripk3-gfp fl/fl ) mice by crossing the Ripk3-gfp fl/fl reporter mice with CD11c (Itgax)-Cre transgenic mice. Flow cytometry confirmed that the GFP fluorescence signal was lost in CD11c + cells ( Figure 5A ). Consistent with the reported weak activity of the CD11c-Cre transgene in T and B cells (Caton et al., 2007) , we also observed slight reduction in GFP signals in these cells. When the CD11c:Ripk3-gfp fl/fl mice were challenged with DSS, they exhibited much more severe body weight loss and shortening of the colon than Ripk3-gfp fl/fl littermates (Figures 5B and 5C ). Similar to Ripk3 À/À mice (Moriwaki et al., 2014), CD11c:Ripk3-gfp fl/fl mice produced significantly reduced IL-22, a critical promoter of tissue repair, in the colon after DSS treatment than littermate controls ( Figure 5D ). In addition, expression of IL-23 and IL-1b, which stimulate IL-22 production by type 3 innate lymphoid cells (Lee et al., 2013) , was also significantly suppressed in the colon of DSStreated CD11c:Ripk3-gfp fl/fl mice ( Figure 5D ). By contrast, TNF expression, which was normal in DSS-treated Ripk3 À/À mice , was also unaffected in CD11c:Ripk3gfp fl/fl mice ( Figure S4A ). The number of T cells, B cells, and CD11c + and CD11b + MNPs in the intestinal lamina propria was similar in Ripk3-gfp fl/fl and CD11c:Ripk3-gfp fl/fl mice ( Figures  S4B and S4C ). In addition, the percentage of type 3 innate lymphoid cells and RIPK3 in these cells was also unchanged in CD11c:Ripk3-gfp fl/fl mice ( Figures S4D and S4E) . These results are consistent with those observed in germline Ripk3 À/À mice and indicate that RIPK3 promotes optimal expression of repair-associated cytokines by CD11c + cells in a cell-intrinsic manner.
The Role of Colonic CX 3 CR1 + MNPs in RIPK3-Dependent Cytokine Expression
Colonic CD11c + cells are subdivided into two main populations: CD11c + CD11b + CD103 À and CD11c + CD11b À CD103 + cells (Figure S2C ) . Whereas CD11c + CD11b À CD103 + cells are considered to be conventional DCs developed from common DC precursors, CD11c + CD11b + CD103 À cells are developed from monocytes and express both DC and macrophage markers (Cerovic et al., 2014) . Within the CD11c + CD11b + CD103 À MNPs, the chemokine receptor CX 3 CR1 was reported to mark a population of cells that are the main source of IL-23 and IL-1b during intestinal inflammation (Longman et al., 2014) . We therefore tested the role of RIPK3 in cytokine production by the CX 3 CR1 + MNPs. Because no reliable CX 3 CR1 antibody is available for flow cytometry, we used CD14 as a marker to test RIPK3 expression in this population. Consistent with a previous report (Diehl et al., 2013) , we confirmed by using Cx 3 cr1 gfp/+ reporter mice that the CD11c + MHC-II + CD14 + MNPs were indeed exclusively positive for CX 3 CR1 expression ( Figure S5A ). Interestingly, these CD11c + CD11b + CD103 À CD14 + MNPs also expressed high levels of RIPK3 compared with CD11c + CD11b À CD103 + DCs ( Figure 6A ). We isolated CX 3 CR1 + MNPs and CD103 + DCs from colonic lamina propria of untreated Ripk3 +/+ Cx3cr1 gfp/+ and Ripk3 À/À Cx3cr1 gfp/+ mice or the mice challenged with DSS for 7 days and compared their cytokine expression profile ( Figure S5B ). Consistent with a published report (Longman et al., 2014) , Il23p19 and Il1b expression were induced in CX 3 CR1 + MNPs in response to DSS ( Figure 6B ). In contrast, the cytokine expression was undetectable in CD103 + DCs ( Figure 6B ). Strikingly, the expression of Il23p19 was significantly reduced in CX 3 CR1 + MNPs isolated from Ripk3 À/À Cx3cr1 gfp/+ mice compared with those from Ripk3 +/+ Cx3cr1 gfp/+ littermates. The expression of Il1b was also reduced in CX 3 CR1 + MNPs isolated from Ripk3 À/À Cx3cr1 gfp/+ mice, although the difference was not statistically significant. To determine whether CX 3 CR1 + MNPs are responsible for the impaired cytokine expression in CD11c:Ripk3-gfp fl/fl mice, we isolated CD11c + CD11b + CD14 + MNPs from DSS-treated Ripk3-gfp fl/fl and CD11c:Ripk3-gfp fl/fl mice. Indeed, the cells from CD11c:Ripk3gfp fl/fl mice also exhibited reduction in Il1b and Il23p19 expression ( Figure S5C ), although the difference was not statistically significant. Collectively, these results suggest that CX 3 CR1 + MNPs in the lamina propria contribute to injury-induced cytokine expression.
DISCUSSION
RIPK3 is a key signal adaptor for necroptosis. Recently, RIPK3 has also been shown to promote activation of the NLRP3 inflammasome, NF-kB, and apoptosis. The role of RIPK3 in necroptosis-independent signaling is especially prominent in innate immune sentinels such as macrophages and DCs. However, tools that allow Ripk3-gfp fl/fl 0 1 0 2 10 3 10 4 10 5 0 1 0 2 10 3 10 4 10 5 0 1 0 2 10 3 10 4 10 5 0 1 0 2 10 3 10 4 10 5 examination of RIPK3 functions in distinct cell populations have been lacking. In this study, we report two mouse models that address this deficiency. Using the RIPK3-GFP reporter mice, we found that RIPK3 expression is dynamically regulated in different immune subsets. For example, RIPK3 expression was increased in macrophages in response to LPS stimulation. In contrast, RIPK3 expression was strongly induced in T cells during intestinal inflammation. T-cell-receptor-dependent induction of RIPK3 expression suggests that RIPK3 may regulate T cell responses and functions. Indeed, previous studies showed that Fadd À/À Ripk3 À/À and Casp8 À/À Ripk3 À/À mice developed an lpr/ gld-like autoimmune disease (Dillon et al., 2012; Kaiser et al., 2011; Oberst et al., 2011) , indicating that RIPK3 cooperates with FADD/ caspase-8 to enforce peripheral T cell tolerance. Whether RIPK3 regulates other functions in T cells is unknown at present.
Ripk3
In contrast with T cells, RIPK3 has a key role in cytokine expression by DCs and macrophages. RIPK3 expression in CD11c + DCs and CD11b + macrophages was not dramatically altered during LPS-or DSS-induced inflammation, although its expression in these innate immune effectors in different anatomical locations is highly variable. For instance, CD11c + MHC-II + CD11b + MNPs in the colonic lamina propria highly expressed RIPK3 compared with those in spleen and showed the highest RIPK3 expression among various immune cell subsets. These cells have been implicated to be major producers of IL-23 and IL-1b, which in turn stimulate IL-22 production by type 3 innate lymphoid cells (Aychek et al., 2015; Longman et al., 2014; Manta et al., 2013) . Depletion of this population or knockout of CX 3 CR1 exacerbated experimental colitis (Longman et al., 2014; Medina-Contreras et al., 2011) . Although some of the effect might be because of the reduced expression of RIPK3-DRHIM protein, deletion of the RIPK3 RHIM in CD11c + cells alone was sufficient to recapitulate the severe colitis observed in germline Ripk3 À/À mice. This observation strongly suggests that the RHIM is essential for necroptosis-dependent and -independent functions of RIPK3. Ripk3 À/À CX 3 CR1 + MNPs and CX 3 CR1 + MNPs from CD11c:Ripk3-gfp fl/fl mice produced reduced levels of Il-1b, Il23p19, and Il22, although the differences were not always statistically significant. Thus, there may be other immune effectors within the lamina propria that require RIPK3 to achieve optimal cytokine expression.
RIPK3 is widely believed to induce inflammation through necroptosis-associated release of damage-associated molecular patterns (Kaczmarek et al., 2013) . This current dogma is mostly based on studies from mice lacking caspase-8 or FADD, or multiple cellular inhibitor of apoptosis proteins (cIAPs), all of which are strong inhibitors of RIPK3 pro-necroptotic function . It is therefore striking that unlike Ripk3 DR/DR or Cd11c-Cre:Ripk3-gfp fl/fl mice, Ripk3 kd/kd mice did not develop more severe colitis. Thus, in injury-induced cytokine expression and tissue repair, RIPK3 functions exclusively as an inducer of cytokine expression rather than as a cell death adaptor. A necroptosis-independent role for RIPK3 in NLRP3 inflammasome activation has been observed in in vitro studies with BMDMs and BMDCs (Kang et al., 2015; Lawlor et al., 2015; Moriwaki et al., 2015; Vince et al., 2012) . However, as in the case of necroptosis, maximal RIPK3-mediated inflammasome activation also requires FADD, caspase-8, or cIAPs inhibition. Thus, our result demonstrates a necroptosis-independent role for RIPK3 in physiological inflammation without pharmacological or genetic manipulation of FADD, caspase-8, or cIAPs. Our results also reveal that the non-necroptotic functions of RIPK3 may be confined to specific cell compartments. In this scenario, its function can only be revealed using tissue-specific inactivation approaches.
We previously reported that the RIPK3-RIPK1-FADD-caspase-8 complex was formed upon LPS stimulation in BMDCs. Assembly of this ripoptosome-like complex also requires another RHIM-containing adaptor TRIF . Results from this present study indicate that an intact RHIM is not only crucial for necroptosis, but also for RIPK3-dependent ripoptosome assembly and pro-IL-1b processing. However, this function of RIPK3 does not require its pro-necroptotic kinase activity. In contrast, the mechanism by which RIPK3 promotes RelB-p50 activation is less understood. RIPK3 has been impli-cated to shuttle between the cytoplasm and nucleus (Yang et al., 2004; Yoon et al., 2016) , suggesting that RIPK3 may directly engage the transcriptional machinery under certain conditions.
EXPERIMENTAL PROCEDURES Mice
To generate Ripk3-gfp fl/fl reporter mice, we created a targeting construct in which an eGfp sequence was inserted at the end of the coding region of the Ripk3 gene. The neomycin resistance gene flanked by flippase recognition target (FRT) sites was inserted in intron 9 for positive selection. For negative selection, thymidine kinase was added outside the 5 0 homology arm. LoxP sites were also inserted before the neomycin cassette and after the EGFP sequence. Embryonic stem (ES) cells were transfected with the targeting construct and subsequently selected by neomycin in the transgenic animal core at the University of Massachusetts Medical School (UMMS). ES clones in which proper recombination occurs were selected by Southern blot analysis, with probe 1 located in the 5 0 homology arm and probe 2 located outside the 3 0 homology arm and subsequently used for injection into albino C57BL/6 blastocysts to generate chimeric mice. Germline transmission of the transgene was confirmed by Southern blot analysis. The neomycin cassette was removed by crossing the Ripk3-gfp flox-neo/+ mice with the flippase transgenic mice [Gt(ROSA)26Sor tm1(Flp1)Dym , kindly provided from S. Jones in UMMS]. To generate mice constitutively deficient for the Ripk3 RHIM, we crossed Ripk3-gfp flox-neo/+ mice with Sox2-Cre transgenic mice (kindly provided from S. Jones in UMMS). The resultant Ripk3 fl/+ and Ripk3 DRHIM/+ mice were backcrossed with C57BL/6 mice for 8-10 generations. To delete the RHIM specifically in CD11c + cells, we crossed Ripk3-gfp fl/fl mice with CD11c (Itgax)-Cre transgenic mice obtained from The Jackson Laboratory. Ripk3 À/À mice were obtained from Genentech. Fadd À/À mice were described before (Zhang et al., 2011) . Ripk3 K51A kinase dead knock-in (Ripk3 kd/kd ) mice were generated in GlaxoSmithKline (Mandal et al., 2014) . Cx3cr1 gfp/gfp reporter mice were obtained from The Jackson Laboratory. All animal experiments were approved by the institutional animal care and use committee. The RIP3-GFP floxed mice are available at The Jackson Laboratory as Stock No. 030284.
DSS Treatment
Female mice (9-12 weeks old) were treated with 3% DSS (molecular mass 36,000-50,000 Da; MP Biomedicals) for 7 days. The DSS water was replaced with fresh DSS water on days 3 and 5 and with regular water on day 8. Body weight was monitored for 15 days, and the weight at the beginning of the experiments was normalized as 100%. To obtain Ripk3 +/À control mice with a minimum difference of genetic background, we crossed Ripk3 kd/+ mice with Ripk3 À/À mice. The resultant Ripk3 kd/À or Ripk3 +/À mice were intercrossed to obtain Ripk3 kd/kd or Ripk3 +/À mice. After weaning, these mice were co-housed Figure S5 .
to minimize the influence of intestinal microflora. All experiments, except for the ones using Ripk3 kd/kd mice, were performed using littermates. To minimize the differences in intestinal microbial environment among cages, we mixed bedding materials from different cages once a week after weaning.
Flow Cytometry
Colon was harvested from untreated or DSS-treated mice. After removing feces with PBS, the colon was longitudinally opened and cut into three pieces. The tissues were washed with PBS and subsequently incubated in 1 mM DTT for 10 min at room temperature (RT). Then, the tissues were shaken in 10 mM HEPES buffer containing 30 mM EDTA for 10 min at 37 C (225 rpm). After washing, the tissues were digested with 0.5 mg/mL collagenase IV (Sigma) and 150 mg/mL DNase I (Sigma) for 90 min at 37 C. Tissues were broken by vigorously shaking, filtered, and subjected to Percoll density gradient separation. LPMCs at the interphase of the two Percoll solutions were collected and subjected to flow cytometric analysis. To isolate splenocytes, we incubated spleen with 2 mg/mL collagenase D solution (10 mM HEPES [pH 7.4], 150 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 ) for 30 min at 37 C. After gliding the spleen, red blood cells were lysed with ACK lysis buffer (150 mM NH 4 Cl, 10 mM KHCO 3 , 0.1 mM EDTA). Splenocytes were filtered and subjected to flow cytometric analysis. Prior to incubation with primary antibodies, cells were incubated with anti-Fc receptor 2. 
T Cell Stimulation
A 24-well tissue culture plate was coated with 10 mg/mL anti-CD3 (145-2C11) and 5 mg/mL anti-CD28 (37.51) antibodies at 4 C overnight. Splenocytes were plated onto the coated plate. For Con A stimulation, splenocytes were plated onto uncoated plate and stimulated with 5 mg/mL Con A. After 3 days, the cells were subjected to flow cytometric analysis.
Western Blot
Cell lysates prepared using radio-immunoprecipitation assay (RIPA) lysis buffer supplemented with protease (Roche) and phosphatase inhibitors (Sigma) were subjected to SDS-PAGE. Nuclear extracts were prepared as described before . After transferring proteins to nitrocellulose membrane, immunoblot analysis was performed with the following antibodies: anti-RIPK3 (2283, RIPK3-P; Prosci), anti-mouse RIPK3 (clone 1G6.1.4, RIPK3-G; Genentech), anti-HSP90 (68/Hsp90; BD Biosciences), anti-HA, anti-RelB (C1E4; Cell Signaling), anti-p50 (H-119; Santa Cruz), anti-BRG1 (kindly provided by A. Imbalzano), anti-caspase-8 (1G12; Enzo Lifesciences), anti-pro-IL-1b (AF-401-NA; R&D Systems), and anti-caspase-3 (46; Santa Cruz) antibodies.
Cell Culture and Stimulation BM cells were cultured for 7 days in either RPMI media supplemented with 10 ng/mL GM-CSF and 5 ng/mL IL-4 to generate BMDCs or L929-conditioned media to generate BMDMs . Ripk3 +/+ , Ripk3 À/À , Ripk3 DR/DR MEFs, Ripk3 À/À 3T3, and 293T cells were cultured in DMEM media. Ten percent fetal calf serum, 2 mM glutamine, 100 U/mL penicillin, and 100 mg/ mL streptomycin were added to the media. Purified LPS from Invivogen was used for all experiments. In some experiments, cells were pretreated with zVAD-fmk (Enzo Lifesciences), CHX (Sigma), BV6 (kindly provided from D. Vucic in Genentech), and/or RIPK3 kinase inhibitor GSK2393843A (GSK'843; GlaxoSmithKline) for an hour prior to LPS, TNF, or polyIC stimulation, unless otherwise stated. After stimulation, culture media and cells were used for cell death assay, ELISA, RNA, and protein analyses. Caspase-1 activity was measured by caspase-1 substrate YVAD-7-amido-4-trifluoromethylcoumarin (YVAD-AFC) (BioVision).
qPCR Total RNA was extracted from cells and tissues using RNeasy Mini kit (QIAGEN) and subjected to reverse transcription using Superscript III (Invitrogen). Real-time PCR analysis using iQ SYBR Green Supermix (Bio-Rad Laboratories) was performed on C1000 thermal cycler and CFX96 real-time system (Bio-Rad laboratories). The following primers were used: 5 0 -TTGAGGTGTCCA ACTTCCAGCA-3 0 and 5 0 -AGCCGGACATCTGTGTTGTTA-3 0 for Il22, 5 0 -CCAG CGGGACATATGAATCT-3 0 and 5 0 -AGGCTCCCCTTTGAAGATGT-3 0 for Il23a (Il23p19), 5 0 -CCCAACTGGTACATCAGCAC-3 0 and 5 0 -TCTGCTCATTCACGAA AAGG-3 0 for Il1b, 5 0 -TGTCAAGTTATGGCCTACTGGTGCG-3 0 and 5 0 -AACCAT AGCCTTCACCTCCCAGGAT-3 0 for Ripk3, and 5 0 -CAAACCCAGAATTGTTCT CCTT-3 0 and 5 0 -ATGTGGTCTTCCTGAATCCCT-3 0 for Tbp.
Cell Death Assay
Cell death was determined by CellTiter-Glo Luminescent Cell Viability Assay (Promega), CytoTox 96 Non-Radioactive Cytotoxicity Assay (Promega), or CellTiter 96 AQ ueous One Solution Cell Proliferation Assay (Promega). All cell death assays were performed in triplicates.
3 0 -RACE PCR DNA sequence of the 3 0 region of Ripk3 DR mRNA was determined by 3 0 -RACE experiment (Scotto-Lavino et al., 2006) . Total RNA was extracted from Ripk3 DR/DR MEFs and reverse transcribed using Q total primer (5 0 -CCAGTGAG CAGAGTGACGAGGACTCGAGCTCAAGCTTTTTTTTTTTTTTTTT-3 0 ) and Superscript III. First PCR was performed using Q outer primer (5 0 -CCAGTGAGCAG AGTGACG-3 0 ) and gene-specific primer (GSP) 1 (5 0 -TGCTGCTGTCTCCGAG GTAAAG-3 0 ). PCR product was subjected to second PCR using Q inner primer (5 0 -ATCGGATCCGAGGACTCGAGCTCAAGC-3 0 ) and GSP2 (5 0 -ATCGAATTC CAAAGGAATCAGGGAGATGGAAG-3 0 ). Pfu Turbo DNA polymerase AD was used for PCR. PCR product was run on a 1% agarose gel and purified from the gel. The purified products were digested by EcoRI and HindIII, and subsequently cloned into pUC19 vector. DNA sequence was determined by sequence analysis.
Plasmids, Viruses, Transfections, and Transductions
Mouse wild-type Ripk3 gene and Ripk3 DR short and long isoforms were cloned into a modified lentiviral tet-on pTRIPZ/Puro vector. HA tag was introduced at the amino terminus of RIPK3 by PCR cloning. The sequence of all the genes inserted was confirmed by sequence analysis. Ripk3 À/À 3T3 cells were transduced by lentivirus generated in 293T cells with pTRIPZ, pMD2.G, and psPAX2 vectors. After transduction, the cells were selected by 2 mg/mL puromycin.
Statistical Analysis
The p values were calculated using unpaired t test with Welch's correction or two-way repeated-measures ANOVA. The p values <0.05 were considered statistically significant. 
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